GS
Gilead Sciences, Inc. disclosed a 9.9% stake in ASPE
Gilead Sciences, Inc. reported owning 9.9% of Aspen Neuroscience, Inc. (ASPE) (2,879,996 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G